Business Context and Reporting Period
This Form 8-K is filed by Owens & Minor, Inc. (not Accendra Health Inc.) on June 21, 2024, reporting executive leadership changes effective June 21, 2024. The filing details the departure of the Chief Financial Officer and the appointment of an interim successor.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and severance arrangements.
- Outgoing CFO Base Salary: $525,000
- Outgoing CFO Severance: Lump-sum equal to 1.5x (Base Salary + Average Actual Bonus for 2021-2023)
- COBRA Coverage: $25,000 lump-sum for 18 months of employer premiums
- Outplacement Services: Up to $10,000
- Tax/Financial Counseling: Up to $5,250
- Interim CFO Equity Award: $250,000 grant date fair value in restricted stock units
Material Changes
The primary material change is the restructuring of the executive leadership team:
- Departure: Alexander J. Bruni resigned as Executive Vice President & Chief Financial Officer effective June 21, 2024, at the Company's request. He will remain until September 5, 2024, to assist with the transition.
- Appointment: Jonathan A. Leon, previously Senior Vice President and Corporate Treasurer, was appointed Interim Chief Financial Officer effective June 21, 2024.
Outlook, Risks, and Unusual Items
Management Commentary: The Company states Mr. Bruni will depart to pursue opportunities outside the Company. Mr. Leon brings experience in global treasury, corporate development, taxation, and investor relations, having joined the Company in 2017.
Restrictive Covenants: As part of the separation, Mr. Bruni has agreed to confidentiality, non-disparagement, non-competition, and non-solicitation covenants.
Equity Vesting: A pro-rata portion of Mr. Bruni's unvested restricted stock units will vest as of the Separation Date.
Unusual Items: The filing notes that the full text of the Transition Agreement will be filed in the subsequent Form 10-Q for the quarter ended June 30, 2024.
Investor Verification Checklist
- Verify the exact calculation of Mr. Bruni's average bonus for 2021-2023 to determine total severance liability.
- Review the upcoming Form 10-Q for the full text of the Transition Agreement and details on the pro-rata vesting of Mr. Bruni's equity.
- Confirm the timeline for the transition period ending September 5, 2024, and any interim financial reporting impacts.
- Monitor for a permanent CFO appointment following the interim period.